Page results
-
Patients with COVID-19 will be given the cystic fibrosis drug ‘Dornase alfa’ to determine if it can help improve survival by reducing excess inflammation in the lungs in a trial at UCLH.
-
This page is for parents and carers whose child is having radiotherapy treatment to the pelvis.
-
Neurological complications of COVID-19 can include delirium, brain inflammation, stroke and nerve damage, finds a new UCL and UCLH-led study.
-
UCLH will be part of a major UK research study looking at the long-term health impacts of COVID-19.
-
A research team involving UCLH clinicians has found a way to reduce the side effects of treatment for a disorder of the adrenal glands.
-
An exciting new project to recycle packaging from single-use items is projected to reduce the waste being incinerated from UCLH theatres by around 215kg a year.
-
Robot-assisted surgery used to perform bladder cancer removal and reconstruction enables patients to recover far more quickly and spend significantly less time in hospital, concludes a trial led by UCLH, UCL and the University of Sheffield.
-
This page has been written for patients who are having radioactive iodine (131I) ablation and/or radioiodine treatment for thyroid cancer.
-
This service is provided for UCLH patients who are unable to attend hospital appointments by public transport or other means, due to their medical condition.
-
UCLH is making the change from single use to named reusable fabric theatre hats for staff working in operating theatres.
File results
-
FOI/2023/0082 - Organisation structure for Performance and Planning department
-
FOI/2023/0083 - Software systems/ suppliers used at Trust
-
FOI/2023/0086 - Number/ wait times for MRI scans for multiple sclerosis/ dementia/ prostate/ pancreatic cancer
-
FOI/2021/0284 - Sleep respiratory service
-
FOI/2023/0099 - Number of autoclaves used at Trust
-
FOI/2023/0101 - Trauma protocols in pregnant patients
-
FOI/2023/0103 - Genetic Haemochromatosis patients
-
FOI/2023/0145 - Waiting times for consultant-led treatment, inpatient and outpatients
-
FOI/2023/0143 - Immunoassay Analysers at Trust
-
FOI/2023/0142 - Treatment of breast cancer